班长丸山幸

1122-12-233-13-24122-12-22-3122-42-5X2-62-73ICUCCU3-13-23-33-411-11-21-31-41-522-12-22004-2005GuidelinesforTreatmentofAcuteHeartFailure(JCS2006)hY2006112-32-433-13-23-33-43-53-63-744-14-24-34-44-54-64-755-1ACLS5-25-3IABP,PCPS,5-45-55-65-71233-1HCM3-2DCM44-14-24-355-1mitralstenosisMS5-2mitralregurgitationMR5-3aorticstenosisAS5-4aorticregurgitationAR12344-155-15-212345611-11-222004-2005ACCAmericanCollegeofCardiologyACEangiotensinconvertingenzymeACLSAdvancedCardiovascularLifeSupportACTacceleratedcoagulationtimeADHantidiuretichormoneAfatrialfibrillationAHAAmericanHeartAssociationALTalanineaminotransferaseAMIacutemyocardialinfarctionANPatrialnatriureticpeptideAPTTactivatedpartialthromboplastintimeARaorticregurgitationARBangiotensinreceptorblockerARDSadultrespiratorydistresssyndromeASaorticstenosisASTaspartateaminotransferaseATPadenosinetriphosphate3AVPargininevasopressinAVRaorticvalvereplacementBiPAPbilevelpositiveairwaypressureBiVASbiventricularassistsystemBLSBasicLifeSupportBNPbrainnatriureticpeptideBSAbodysurfaceareaCacalciumCABGcoronaryarterybypassgraftingcAMPcyclicadenosinemonophosphateCASTCardiacArrhythmiaSupressionTrialCCUcoronarycareunitCHDFcontinuoushemodiafiltrationCHARMCandesartaninHeartFailure-AssessmentofReductioninMortalityandMorbidityCIcardiacindexCKcreatinekinaseCONSENSUSCooperativeNorthScandinavianEnaraprilSurvivalTrialCOPcolloidosmoticpressureCPAPcontinuouspositiveairwaypressureCPPVcontinuouspositivepressureventilationCPRcardiopulmponaryresuscitationCRPC-reactiveproteincCRTcardiacresynchronizationtherapyCTcomputerizedtomographyCVPcentralvenouspressureCVVHcontinuousveno-venoushemofiltration-DCMdilatedcardiomyopathyDIGDigitalisInvestigationGroupTrialECUMextracorporealultrafiltrationmethodEmaxmaximumelastanceEPHESUSEplerenonePost-AMIHeartFailureEfficacyandSurvivalStudyFDAFoodandDrugAdministrationFDPfibrindegradationproductFIO2inspiredoxygenfractionalconcentrationFIRSTFlolanInternationalRandomizedSurvivalTrialGESICAGrupodeEstudiodelaSobrevidaenlaInsuficienciaCardiacaenArgentinaGFRglomerularfiltrationratehANPhumanatrialnatriureticpeptideHCMhypertrophiccardiomyopathyHCUhighcareunitHDhemodialysisHNCMhypertrophicnon-obstructivecardiomyopathyHOCMhypertrophicobstructivecardiomyopathyHRheartrateIABPintraaorticballoonpumpingICDimplantablecardioverterdefibrillatorICUintensivecareunitIL-6interleukin-66INRinternationalnormalizedratioIPPBintermittentpositivepressurebreathingISDNisosorbidedinitrateLDHlacticdehydrogenaseLVASleftventricularassistsystemLVEFleftventricularejectionfractionMBPmeanbloodpressureMIRACLEMulticenterInsyncRandomizedClinicalEvaluationMRmitralregurgitationMRSAmethicillin-resistantstaphylococcusaureusMSmitralstenosisMVAmitralvalveareaMVO2myocardialoxygenconsumptionMVRmitralvalvereplacementNF-kBnuclearfactor-kappaBNIPPVnoninvasivepositivepressureventilationNOnitricoxideNYHANewYorkHeartAssociationOMCopenmitralcommissurotomyPCIpercutaneouscoronaryinterventionPCPSpercutaneouscardiopulmonarysupportPCWPpulmonarycapillarywedgepressure3PDperitonealdialysisPDEphosphodiesterasePEEPpositiveend-expiratorypressurePSVTparoxysmalsupraventriculartachycardiaPTprothrombintimePTACpercutaneoustransluminalaorticcommissurotomyPTCApercutaneoustransluminalcoronaryangioplastyPTMCpercutaneoustransluminalmitralcommissurotomyPTSMAPercutaneoustransluminalseptalmyocardialablationPVApressure-volumeareaQOLqualityoflifeRAArenin-angiotensin-aldosteroneRALESRandomizedAldactoneEvaluationStudyREMATCHRandomizedEvaluationofMechanicalAssistancefortheTreatmentofCongestiveHeartFailureSAMsystolicanteriormotionofmitralvalveleafletSAVESurvivalandVentricularEnlargementTrialSIMVsynchronizedintermittentmandatoryventilationSOLVDStudiesofLeftVentricularDysfunctionSVRsystemicvascularresistanceTAHtotalartificialheartTdPtorsade(s)depointesTNFtumornecrosisfactort-PAtissueplasminogenactivatorTRtricuspidregurgitationTStricuspidstenosisVABvenoarterialbypassVAPventilator-associatedpneumoniaVASventricularassistsystemV-Aveno-arterialV-VECMOveno-venousextracorporealmembraneoxygenationZEEPzeroend-expiratorypressure42004-20052000JapaneseCirculationJournal64Suppl1129-1165ACLSabABC562004-2005611XX90%PagetNYHANewYorkHeartAssociation22acutemyocardialinfarc-tion,AMIKillip3Forrester1aKillipClass6%Class17%Class38%Class81%3Forrestersubset2.2%10.1%22.4%55.5%411KillipForrestermmHg--*-1---29090-18mmHg7FraminghamStudy451sm50%50%90mmHgNaa.Forresterb.L/min/m2hypovolemicshockcardiogenicshock2.2018mmHgdry-warmAwet-warmBdry-coldLwet-coldC222121216cmH2O251312054.5kg1182004-200552X90mmHg30mmHgCheyne-StokesNohriaProfileAL1bProfileAdry-warmProfileBwet-warmProfileCwet-coldProfileLdry-coldProfileBC661772233319BNPProfileA1b1123intraaorticballoonpumping;IABP12abc3456789101112131415abcdefghijk16abcdefPaget71abc2abcd1RAA234567123432102004-2005XD-XXCT1234idiopathicpulmonaryarterialhypertensionCaI22889590mmHgBLSACLSFiO2NIPPVIPPV44111312367Fowler**FowlerCO224CCCUHCUICUC24CC24XCCHolterCCSwan-GanzCCCCCCC112221122004-20055RAA215Killip312Swan-GanzX221320mmHg2.2Lminm2ForresterNohria41b681